1. Home
  2. PLTK vs GLPG Comparison

PLTK vs GLPG Comparison

Compare PLTK & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLTK
  • GLPG
  • Stock Information
  • Founded
  • PLTK 2010
  • GLPG 1999
  • Country
  • PLTK Israel
  • GLPG Belgium
  • Employees
  • PLTK N/A
  • GLPG N/A
  • Industry
  • PLTK EDP Services
  • GLPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLTK Technology
  • GLPG Health Care
  • Exchange
  • PLTK Nasdaq
  • GLPG Nasdaq
  • Market Cap
  • PLTK 2.0B
  • GLPG 1.9B
  • IPO Year
  • PLTK 2021
  • GLPG 2005
  • Fundamental
  • Price
  • PLTK $4.76
  • GLPG $30.32
  • Analyst Decision
  • PLTK Buy
  • GLPG Sell
  • Analyst Count
  • PLTK 7
  • GLPG 4
  • Target Price
  • PLTK $7.68
  • GLPG $25.33
  • AVG Volume (30 Days)
  • PLTK 1.8M
  • GLPG 239.4K
  • Earning Date
  • PLTK 08-06-2025
  • GLPG 07-23-2025
  • Dividend Yield
  • PLTK 8.47%
  • GLPG N/A
  • EPS Growth
  • PLTK N/A
  • GLPG N/A
  • EPS
  • PLTK 0.37
  • GLPG N/A
  • Revenue
  • PLTK $2,604,100,000.00
  • GLPG $311,493,731.00
  • Revenue This Year
  • PLTK $13.29
  • GLPG $0.78
  • Revenue Next Year
  • PLTK $3.91
  • GLPG N/A
  • P/E Ratio
  • PLTK $12.61
  • GLPG N/A
  • Revenue Growth
  • PLTK 1.64
  • GLPG 18.32
  • 52 Week Low
  • PLTK $3.97
  • GLPG $22.36
  • 52 Week High
  • PLTK $8.80
  • GLPG $31.23
  • Technical
  • Relative Strength Index (RSI)
  • PLTK 46.54
  • GLPG 67.62
  • Support Level
  • PLTK $4.80
  • GLPG $28.21
  • Resistance Level
  • PLTK $5.05
  • GLPG $30.64
  • Average True Range (ATR)
  • PLTK 0.16
  • GLPG 0.52
  • MACD
  • PLTK 0.01
  • GLPG 0.23
  • Stochastic Oscillator
  • PLTK 54.62
  • GLPG 91.29

About PLTK Playtika Holding Corp.

Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: